Cogent Biosciences, Inc. (COGT) Financials

COGT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 903.0 million 295.3 million
Dec. 31, 2025 937.6 million 301.2 million
Sept. 30, 2025 425.9 million 123.5 million
June 30, 2025 274.8 million 119.8 million

COGT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -87.3 million 16.9 million
Dec. 31, 2025 -79.9 million 15.8 million
Sept. 30, 2025 -64.4 million 10.6 million
June 30, 2025 -54.7 million 9.7 million

COGT Net Income

No data available :(

COGT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 866.4 million 223.2 million 14.1 million
Dec. 31, 2025 900.8 million 237.3 million 14.4 million
Sept. 30, 2025 390.9 million 44.3 million 16.3 million
June 30, 2025 237.8 million 43.9 million 16.7 million

COGT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 67.4 million
Dec. 31, 2025 67.6 million
Sept. 30, 2025 114.5 million
June 30, 2025 114.5 million

COGT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 449000 75.4 million 28.2 million -
Dec. 31, 2025 811000 74.4 million 23.9 million -
Sept. 30, 2025 65000 69.0 million 14.4 million -
June 30, 2025 131000 61.0 million 13.4 million -

COGT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 1.2 million
Dec. 31, 2025 - 1.2 million
Sept. 30, 2025 - -
June 30, 2025 - 1.2 million

COGT

Price: $33.44

52 week price:
5.49
43.73

Earnings Per Share: -2.17 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 528500

Ebitda: -29.7 million

Market Capitalization: 5.3 billion

Links: